#USA #Pittsburgh #PANTHERx #Rare Disease #Care Coordination

Strengthening Care Coordination in Rare Disease Management

As February 28 approaches, marking Rare Disease Day, the spotlight is on the rare disease community, which faces both challenges and hopeful advancements. According to recent research by PANTHERx, which seeks to illuminate the experiences of patients, caregivers, and healthcare professionals, there’s a significant need for better care coordination amidst a record number of new therapies nearing FDA approval. This article dives deep into the findings of this research and highlights key issues that remain prevalent in rare disease care.

The Landscape of Rare Disease Medications

PANTHERx's report indicates a promising trend for rare disease medications, with estimates suggesting that between 40 and 45 new therapies are expected to be introduced in the United States within the next 18 months. This influx signifies a critical moment for the rare disease community, which often finds itself navigating complex healthcare landscapes with limited support.

The research, conducted in collaboration with Morning Consult, surveyed 226 stakeholders in the rare disease space—including patients, caregivers, healthcare providers, and payers—between January 27 and February 11, 2026. The findings reveal pressing communication and coordination gaps that delay care and add undue burdens to patients and their families.

Key Findings: Communication Gaps and Patient Burden

Communication Barriers Are Widespread

The research unveiled that despite advancements in therapy availability, 90% of patients and caregivers experience delays primarily due to communication issues—highlighting a critical area for improvement. An overwhelming 68% expressed frustration regarding unclear insurance coverage and lack of updates from healthcare providers.

More concerning, more than half of those surveyed reported feeling solely responsible for determining next steps in their care journey. This pressure underscores the lack of a structured support system, leading to increased stress for patients and caregivers who are already dealing with the complexities of rare diseases.

The Need for Personalized Support

Interestingly, the majority of patients desire more tailored care. Approximately 72% indicated that having dedicated coordinators who maintain ongoing relationships with them would be immensely beneficial. Patients are not merely looking for medication but for comprehensive support that acknowledges the uniqueness of their circumstances.

Yet, less than 10% reported facing no obstacles during diagnosis or when initiating treatment. This statistic further emphasizes the widespread lack of personalized support—47% noted that the care they received felt generic rather than individualized.

A Unified Approach to Care Coordination

Crucially, the study revealed a consensus among stakeholders: establishing a single point of coordination is vital for alleviating delays and simplifying the care process. About 73% of both patients and healthcare professionals agree that clear accountability for care coordination would significantly enhance outcomes.

This finding aligns with the ideal vision presented by many patients, who expressed a desire for a primary partner—one who would understand their situation thoroughly and coordinate logistics across various healthcare touchpoints, including doctors, insurers, and pharmacies.

The Role of PANTHERx in Enhancing Rare Disease Care

Dr. Richard Faris, Chief Commercial and Clinical Officer at PANTHERx Rare, emphasizes the necessity of addressing these systemic issues. He articulates that while therapeutic innovations are crucial, they are insufficient without coordinated navigation and communication in care management.

PANTHERx has made strides in this direction with its RxARECARE® model, which focuses on highly personalized care through sustained coordination and advocacy for patients. This approach aims to reduce the fragmentation of care, anticipating barriers, and easing the burden typically placed on patients and caregivers.

Conclusion: Moving Forward Together

As Rare Disease Day approaches, the insights from PANTHERx emphasize the urgent need for a unified effort to improve care coordination. This research serves as a call to action for stakeholders across the healthcare system to prioritize effective communication and coordinated care strategies. Only then can the promising advancements in rare disease therapies translate into meaningful, long-lasting improvements in patients' lives.

For those interested in diving deeper into the nuances of this research, the full summary report is available for download on PANTHERx's official website. By fostering a more supportive and connected healthcare environment, collective efforts can pave the way for a brighter future for patients with rare diseases.